NovoLog® (insulin aspart injection) 100 U/mL is a rapid-acting insulin analog that is engineered for mealtime use. Compared with subcutaneously administered regular human insulin, NovoLog® has a faster onset of action, an earlier and higher peak concentration, and a shorter duration of action. NovoLog® can help control mealtime glucose spikes, without the “long tail” of regular human insulin.2-4
Mean free serum insulin concentrations collected in 22 patients with type 1 diabetes for up to 6 hours following a single dose of NovoLog® injected before a meal vs regular human insulin injected immediately before a meal.2
Adapted from Lindholm et al. 1999.2
Onset of action:
Duration of action
Thought leaders talk about bolus insulin therapy, from the role of PPG control in helping to reach A1C goals to improving patient engagement.
NovoLog® (insulin aspart injection) 100 U/mL is an insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus.
NovoLog® continuous subcutaneous infusion route (insulin pump): Do not mix NovoLog® with any other insulin or diluent.
Please click here for Prescribing Information.